|
|
Thomson Financial Business Description:
| The Group's principal activity is providing research and development of biopharmaceutical products. It develops drugs for allergy, inflammation and autoimmune disease. Products include rEV131, rEV576, rEV598 and anti-tick vaccine. The Group operates in The United Kingdom, Rest of Europe and North America. |
|
Alacra Alerts:
 
|
Receive alerts on the latest reports on Evolutec Group plc
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
|
|
